Searchable abstracts of presentations at key conferences in endocrinology

ea0049oc14.1 | Thyroid Cancer | ECE2017

Anti-Mullerian hormone (AMH) in pre-menopausal females after ablative radioiodine (RAI) treatment for differentiated thyroid cancer (DTC): single-center study

Mittica Miranda , Comite Paola , Campana Claudia , Gay Stefano , Mussap Michele , Giusti Massimo

Background: It is generally reported that female fertility is not affected by high-dose RAI treatment. AMH has been considered a reliable and accurate index of ovarian reserve. There are few data on AMH values in thyroid diseases. Recently, in DTC women who had undergone RAI ablation treatment, Acibucu et al. (2016) reported low AMH levels without significant impairment of fertility.Aim: The aim of this single-center study was to evaluate AMH le...

ea0014p215 | (1) | ECE2007

Absence of TSH-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing rhTSH testing

Cecoli Francesca , Andraghetti Gabriella , Ghiara Carla , Briatore Lucia , Cavallero Domenico , Mussap Michele , Minuto Francesco , Giusti Massimo

Some extra-thyroid effects of TSH have been described in vitro and in vivo. TSH has recently been suggested to induce IL-6 secretion from adipocytes. Leptin is the main secretory protein from adipose tissue. Our aim was to evaluate the acute effect of rhTSH-induced TSH surge on serum leptin levels in differentiated thyroid carcinoma (DTC) patients. Ten patients (2 m, 8 f; age range 31–66 years) with stage 1-3 DTC were evaluated during scheduled standard rhTS...